España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Neumora Therapeutics
NMRA
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$10.78
0.53
5.17%
Last update: 10:10 AM
15 minutes delayed
Why is it moving?
Neumora Therapeutics shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced a $20 price target.
Get Report
Watch
Neumora Therapeutics (NMRA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Neumora Therapeutics (NASDAQ:NMRA) Stock
Neumora Therapeutics Stock (NASDAQ: NMRA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 08, 2024
Neumora Therapeutics shares are trading highe...
Benzinga Newsdesk
Mizuho Initiates Coverage On Neumora Therapeu...
Benzinga Newsdesk
Thursday, June 20, 2024
Neumora Initiates Phase 1b Trial for Alzheime...
Benzinga Newsdesk
Tuesday, May 14, 2024
Neumora Therapeutics Initiates Phase 2 Study ...
Benzinga Newsdesk
Tuesday, May 07, 2024
Neumora Therapeutics Reports Q1 Cash, Cash Eq...
Benzinga Newsdesk
Neumora Therapeutics Q1 2024 GAAP EPS $(0.34)...
Benzinga Newsdesk
Monday, April 15, 2024
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
Avi Kapoor
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
Avi Kapoor
Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
Vandana Singh
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Neumora Therapeutics shares are trading lower...
Benzinga Newsdesk
Neumora Therapeutics Announces FDA Clinical H...
Benzinga Newsdesk
Thursday, March 28, 2024
Neumora Therapeutics shares are trading highe...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Neumora ...
Benzinga Newsdesk
Monday, March 18, 2024
JP Morgan Maintains Overweight on Neumora The...
Benzinga Newsdesk
Wednesday, March 13, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
Friday, March 08, 2024
RBC Capital Maintains Outperform on Neumora T...
Benzinga Newsdesk
Thursday, March 07, 2024
Neumora Therapeutics Q4 EPS $(0.71) Misses $(...
Benzinga Newsdesk
Friday, December 22, 2023
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Tuesday, December 12, 2023
Deutsche Bank Initiates Coverage On Neumora T...
Benzinga Newsdesk
Monday, December 04, 2023
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, November 30, 2023
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, November 27, 2023
Neumora Therapeutics Has Initiated A Phase 1 ...
Benzinga Newsdesk
Wednesday, November 08, 2023
Analyst Expectations for Neumora Therapeutics's Future
Benzinga Insights
JP Morgan Maintains Overweight on Neumora The...
Benzinga Newsdesk
Wednesday, November 01, 2023
Neumora Therapeutics Q3 EPS $(1.14) Down From...
Benzinga Newsdesk
Tuesday, October 10, 2023
PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday
Lisa Levin
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Benzinga Insights
Why Neumora Therapeutics Analysts Are Bullish About Major Depressive Disorder Drug
Priya Nigam
JP Morgan Initiates Coverage On Neumora Thera...
Benzinga Newsdesk
B of A Securities Initiates Coverage On Neumo...
Benzinga Newsdesk
William Blair Initiates Coverage On Neumora T...
Benzinga Newsdesk
Guggenheim Initiates Coverage On Neumora Ther...
Benzinga Newsdesk
RBC Capital Initiates Coverage On Neumora The...
Benzinga Newsdesk
Stifel Initiates Coverage On Neumora Therapeu...
Benzinga Newsdesk
Monday, October 02, 2023
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, September 28, 2023
Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday
Lisa Levin
Wednesday, September 20, 2023
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Friday, September 15, 2023
Neumora Therapeutics Indicating $22.10 On 135...
Benzinga Newsdesk
Neumora Therapeutics Prices Initial Public Of...
Benzinga Newsdesk
Thursday, September 14, 2023
Preview: Neumora Therapeutics, Inc Set To IPO Tomorrow
Benzinga Insights
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch